Coronation Fund Managers’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $37.4M | Buy |
96,798
+22,421
| +30% | +$8.31M | 1.43% | 18 |
|
|
2026
Q1 | $21.8M | Sell |
74,377
-84,872
| -53% | -$27.9M | 0.99% | 22 |
|
|
2025
Q4 | $55.8M | Buy |
159,249
+31,754
| +25% | +$10.7M | 2.5% | 11 |
|
|
2025
Q3 | $41.2M | Sell |
127,495
-9,872
| -7% | -$3.07M | 2.15% | 13 |
|
|
2025
Q2 | $53.4M | Buy |
+137,367
| New | +$55.3M | 2.9% | 11 |
|
|
2024
Q4 | – | Sell |
-90,098
| Closed | -$46.9M | – | 51 |
|
|
2024
Q3 | $46.9M | Buy |
90,098
+4,406
| +5% | +$2.35M | 2.6% | 12 |
|
|
2024
Q2 | $46.4M | Sell |
85,692
-103,500
| -55% | -$54.7M | 2.68% | 13 |
|
|
2024
Q1 | $98.1M | Buy |
189,192
+20,290
| +12% | +$10.1M | 2.67% | 7 |
|
|
2023
Q4 | $79.6M | Buy |
168,902
+20,084
| +13% | +$9.29M | 2.22% | 14 |
|
|
2023
Q3 | $64.8M | Buy |
148,818
+59,856
| +67% | +$27.1M | 1.95% | 12 |
|
|
2023
Q2 | $39.5M | Buy |
88,962
+63,163
| +245% | +$29.1M | 1.06% | 38 |
|
|
2023
Q1 | $11.9M | Buy |
25,799
+7,498
| +41% | +$3.57M | 0.32% | 65 |
|
|
2022
Q4 | $9.39M | Sell |
18,301
-561
| -3% | -$285K | 0.26% | 79 |
|
|
2022
Q3 | $8.57M | Sell |
18,862
-393
| -2% | -$188K | 0.46% | 52 |
|
|
2022
Q2 | $9.29M | Sell |
19,255
-24,477
| -56% | -$12.1M | 0.52% | 52 |
|
|
2022
Q1 | $21.5M | Sell |
43,732
-33,004
| -43% | -$15.1M | 0.84% | 32 |
|
|
2021
Q4 | $35.6M | Buy |
76,736
+4,803
| +7% | +$2.02M | 1.31% | 23 |
|
|
2021
Q3 | $26.8M | Hold |
71,933
| – | – | 1.01% | 27 |
|
|
2021
Q2 | $27.5M | Buy |
71,933
+5,749
| +9% | +$2.2M | 0.86% | 26 |
|
|
2021
Q1 | $23.8M | Sell |
66,184
-1,945
| -3% | -$625K | 0.78% | 31 |
|
|
2020
Q4 | $21.9M | Sell |
68,129
-2,497
| -4% | -$766K | 0.7% | 33 |
|
|
2020
Q3 | $19M | Sell |
70,626
-6,585
| -9% | -$1.77M | 0.69% | 30 |
|
|
2020
Q2 | $20.3M | Buy |
77,211
+3,253
| +4% | +$868K | 0.77% | 27 |
|
|
2020
Q1 | $16.8M | Sell |
73,958
-1,293
| -2% | -$352K | 0.8% | 23 |
|
|
2019
Q4 | $22.7M | Buy |
75,251
+4,168
| +6% | +$1.15M | 0.77% | 24 |
|
|
2019
Q3 | $17.1M | Buy |
71,083
+16,489
| +30% | +$4.52M | 0.64% | 31 |
|
|
2019
Q2 | $15.4M | Sell |
54,594
-4,667
| -8% | -$1.27M | 0.56% | 34 |
|
|
2019
Q1 | $17M | Buy |
59,261
+20,434
| +53% | +$5.91M | 0.63% | 29 |
|
|
2018
Q4 | $10.2M | Sell |
38,827
-9,093
| -19% | -$2.5M | 0.49% | 36 |
|
|
2018
Q3 | $13.1M | Sell |
47,920
-15,104
| -24% | -$3.92M | 0.57% | 38 |
|
|
2018
Q2 | $15M | Sell |
63,024
-26,134
| -29% | -$6.05M | 0.58% | 41 |
|
|
2018
Q1 | $19.6M | Sell |
89,158
-4,277
| -5% | -$1M | 0.78% | 31 |
|
|
2017
Q4 | $21M | Sell |
93,435
-1,044
| -1% | -$222K | 0.66% | 38 |
|
|
2017
Q3 | $17.9M | Sell |
94,479
-3,028
| -3% | -$576K | 0.54% | 39 |
|
|
2017
Q2 | $18.3M | Buy |
+97,507
| New | +$17.5M | 0.57% | 41 |
|
Other funds holding ELV
HGIM
FI
DC
CF
MIHAS
Coronation Fund Managers's ELV Position: Q2 2026 in Review
Coronation Fund Managers increased its Elevance Health (ELV) stake by 30% in Q2 2026, buying an estimated $8.31M and bringing the position to 96,798 shares worth $37.4M. The position accounts for 1.43% of the portfolio, ranked #18.
Coronation Fund Managers first reported a position in ELV in Q2 2017 and has held it in 35 quarters since. The position peaked at $98.1M in Q1 2024. 534 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Coronation Fund Managers held 96,798 shares of Elevance Health worth $37.4M as of Q2 2026.
- Coronation Fund Managers bought 22,421 Elevance Health shares in Q2 2026, an estimated $8.31M.
- Elevance Health made up 1.43% of Coronation Fund Managers's portfolio in Q2 2026, its #18 holding.
- Coronation Fund Managers first reported a position in Elevance Health in Q2 2017 and has held it in 35 quarters since.
- Coronation Fund Managers's Elevance Health position peaked at $98.1M in Q1 2024.
- 534 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Coronation Fund Managers's 13F filing for Q2 2026, filed 27 Jul 2026.